| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0049-3848(98)00132-7 |
| P698 | PubMed publication ID | 9851810 |
| P50 | author | Jennifer I Semple | Q56264607 |
| P2093 | author name string | Grant PJ | |
| Stickland MH | |||
| McCormack LJ | |||
| Barrett JH | |||
| P2860 | cites work | Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 |
| Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? | Q33613657 | ||
| Haemostatic function in myocardial infarction | Q34036695 | ||
| Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction | Q34545496 | ||
| Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells | Q35058259 | ||
| Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. | Q50977258 | ||
| The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. | Q51599538 | ||
| Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. | Q54314674 | ||
| Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity | Q68290719 | ||
| Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease | Q68502564 | ||
| Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response | Q69068473 | ||
| Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction | Q69901572 | ||
| Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 | ||
| Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations | Q70322551 | ||
| Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells | Q71940654 | ||
| Haemostatic function and cardiovascular death: early results of a prospective study | Q72423400 | ||
| Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke | Q72773126 | ||
| P433 | issue | 5 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 199-206 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells | |
| P478 | volume | 92 |
| Q36505016 | Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways |
| Q84773372 | Failure to Lyse Venous Thrombi Because of Elevated Plasminogen Activator Inhibitor 1 (PAI-1) and 4G Polymorphism of Its Promotor Genome (The PAI-1/4G Syndrome) |
| Q41061843 | Influence of the coating with extracellular matrix and the number of cell passages on the endothelialization of a polystyrene surface |
| Q40541400 | No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro |
| Q54589738 | The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin. |
| Q40874140 | Umbilical cord endothelial cells expressing large T antigen: comparison with primary cultures and effect of cell age. |
Search more.